The main purpose of this legislation is to reauthorize the National Diabetes Prevention Program, ensuring that it continues to receive funding and support for its operations. The program aims to reduce the incidence of type 2 diabetes by providing resources and support for individuals at risk of developing the disease. Key provisions of the legislation include specific funding allocations for the program over the next several years. The bill sets aside $39.3 million for the fiscal year 2027, with increases each subsequent year up to $59.3 million by fiscal year 2031.